Tayyaba Naz, Saima Ambreen, Hajra Batool, Hassan Mumtaz*, Ahsan Shafiq, Shamim Mumtaz, Tehreem Fatima and Manahil Rahat


End stage renal disease is a huge issue worldwide. This study was done to understand the relationship between complications and co morbids in patients of ESRD. We had 46 patients between the age group 23–77 years, mean age group was 41-60 years who urgently initiated dialysis therapy at Holy Family Hospital, Rawalpindi Medical University between June 2020 and July. We had 29 males and 17 females. 29 patients (63%) were hypertensive & diabetic, while 5 (10.9%) patients had hypertension only, whereas 12 patients (26.1%) had no comorbidities. Uremic encephalitis occurred in 20 (43.5%) of patients, while 19 (41.3%) patients developed pulmonary edema. Sepsis developed in 7 (15.2%) patients. Hypertensive patients developed pulmonary edema in 3 (60%) of the patients, followed by Uremic Encephalitis and sepsis in 1 patients (20% each). 15 patients (51.7%) of ESRD patients with hypertension and diabetes both developed Uremic Encephalitis, followed by Sepsis in 9 patients (31%) and pulmonary edema in 5 patients (17.2%). Our study had certain limitations, because of time constraints we could not retain patients for much longer period to observe changes in various other parameters. Controlling blood pressure and blood sugar levels can lead to a decrease in the development of various complications as well as co morbids in ESRD patient, thus decreasing the number of hospital visits and increasing survival rate leading to decreasing the burden on our health care system.

Keywords: ESRD, morbids.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    JANUARY 2020 Issue has been successfully launched on 1 January 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction